Indications and uses
Hand and skin anti-microbial to help decrease pathogens (bacteria & germs) on the skin. Recommended for repeated use
Hand and skin anti-microbial to help decrease pathogens (bacteria & germs) on the skin. Recommended for repeated use
Apply a small amount into palms and spread on both hands. Rub into skin until dry. Repeat as necessary.
Benzalkonium Chloride 0.13%
Antiseptic Hand Sanitizer
Hand and skin anti-microbial to help decrease pathogens (bacteria & germs) on the skin. Recommended for repeated use
Do not freeze For external use only
in ears or mouth.
Apply a small amount into palms and spread on both hands. Rub into skin until dry. Repeat as necessary.
Water, Polyaminopropyl biguanide, 1-Octadecanaminum NN dimethyl (3- trimethoxysily) propyl chloride, C12-15 Pareth 12, Caprylyl Glucoside, Sodium Benzoate, Glycerin, Aloe Barbadensis Leaf Juice Extract, Citric Acid
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 80254-000 | 80254-000-00, 80254-000-01, 80254-000-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| POLYAMINOPROPYL BIGUANIDE | DT9D8Z79ET | IACT |
| CAPRYLYL GLUCOSIDE | V109WUT6RL | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| ALOE VERA LEAF | ZY81Z83H0X | IACT |
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2cd80b76-788e-d75e-e063-6394a90af3b8 | ae7ef91c-261a-ca13-e053-2995a90a54a7 | 2025-01-29 | Warnings | ae7ef91c-261a-ca13-e053-2995a90a54a7 |
Adverse event summaries are temporarily unavailable. Other product information remains available.